FDA label 794ec692-f58c-4efd-b341-9b86ae3449f8

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID: 802460ab-999e-43ee-89fb-dfe27a10ab2e
SPL ID: 794ec692-f58c-4efd-b341-9b86ae3449f8
Version: 1
Effective date: 2013-05-06
Source export date: 2026-09-28
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:41:06

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 2 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
spl id		794ec692-f58c-4efd-b341-9b86ae3449f8	id
spl set id		802460ab-999e-43ee-89fb-dfe27a10ab2e	set_id

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For oral use only. When using this product avoid contact with eyes. In case of accidental contact with eyes, flush with water and immediately seek professional help. Ask a doctor before use if you are taking minocycline, doxycycline, tetracycline or are on coumadin therapy, zinc treatment may inhibit the absorption of these medicines. Stop use and ask your healthcare practitioner if symptoms persist beyond 7 days. COLD-EEZE ® Oral Spray is formulated to reduce the duration of common cold symptoms and may be insufficient treatment for Influenza or Allergies. If pregnant or breast-feeding, ask a healthcare practitioner before use. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.